Biogen Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
7.5
Buy
Overall
6.3
Hold
Quality
Health
Growth
Valuation
Sentiment
BIIB
Clean balance sheet with low leverage (0.4× debt-to-equity).
UNH
82% of 28 covering analysts rate it Buy or Strong Buy.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $212.51 (+10.8%)
29 analysts
BUY
Target $387.27 (+5.1%)
26 analysts
Fundamentals
BIIB
UNH
20.6×
Trailing P/E
27.8×
12.0×
Forward P/E
17.8×
13.8%
Profit Margin
2.7%
78.7%
Gross Margin
18.8%
7.7%
ROE
12.2%
1.9%
Revenue Growth
2.0%
31.1%
Earnings Growth
0.7%
0.16
Beta
0.41
—
Price / Book
—
$28.3B
Market Cap
$334.6B
$115 – $202
52-Week Range
$235 – $412
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.